当前位置: X-MOL 学术Cytokine › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
The Interferon-induced transmembrane protein 3 gene (IFITM3) rs12252 C variant is associated with COVID-19
Cytokine ( IF 3.8 ) Pub Date : 2021-01-01 , DOI: 10.1016/j.cyto.2020.155354
Juan Gómez , Guillermo M. Albaiceta , Elías Cuesta-Llavona , Marta García-Clemente , Carlos López-Larrea , Laura Amado-Rodríguez , Inés López-Alonso , Santiago Melón , Marta E. Alvarez-Argüelles , Helena Gil-Peña , José R. Vidal-Castiñeira , Viviana Corte-Iglesias , María L. Saiz , Victoria Alvarez , Eliecer Coto

BACKGROUND AND AIMS The interferon-induced transmembrane proteins play an important antiviral role by preventing viruses from traversing the cellular lipid bilayer. IFITM3 gene variants have been associated with the clinical response to influenza and other viruses. Our aim was to determine whether the IFITM3 rs12252 polymorphism was associated with the risk of developing severe symptoms of COVID-19 in our population. METHODS A total of 288 COVID-19 patients who required hospitalization (81 in the intensive care unit) and 440 age matched controls were genotyped with a Taqman assay. Linear regression models were used to compare allele and genotype frequencies between the groups, correcting for age and sex. RESULTS Carriers of the minor allele frequency (rs12252 C) were significantly more frequent in the patients compared to controls after correcting by age and sex (p = 0.01, OR = 2.02, 95%CI = 1.19-3.42). This genotype was non-significantly more common among patients who required ICU. CONCLUSIONS The IFITM3 rs12252 C allele was a risk factor for COVID-19 hospitalization in our Caucasian population. The extent of the association was lower than the reported among Chinese, a population with a much higher frequency of the risk allele.
更新日期:2021-01-01
down
wechat
bug